Harvard University researchers have identified a unique characteristic of the resistant cancer cells, which could lead to an inhibitor can be repurposed and combined with chemotherapy to improve patient outcomes.
Tags: science-technology chemotherapy david-scadden blood-cancer cell-metabolism resistant-cancer-cells
A new technique called ELeCt (erythrocyte-leveraged chemotherapy) can transport drug-loaded nanoparticles into cancerous lung tissue by mounting them on the body’s own red blood cells.
Tags: science-technology engineering cancer basic-research chemotherapy john-a-paulson-school-of-engineering-and-applied-sciences wyss-institute-for-biologically-inspired-engineering lung-cancer biodegradable-polymer elect erythrocyte-leveraged-chemotherapy trojan-horse
Every year, more than 18 million people around the world are told, “You have cancer.” In the U.S., nearly half of all men and more than one-third of women will develop some kind of cancer during their lifetimes, and 600,000-plus die from it annually. Despite the billions of dollars and countless new treatments that have […]
Tags: inflammation chemotherapy health-medicine artificial-lymph-nodes cancer-research-uks-grand-challenge cancer-treatments cancer-vaccine david-mooney dna-origami donald-ingber mimicking-nature nanoparticle-backpacks organ-chips samir-mitragotri william-shih wyss-institute
Emily Balskus and a team of researchers untangled how soil bacteria are able to manufacture streptozotocin, an antibiotic and anti-cancer compound.
Tags: science-technology chemistry cancer bacteria biology basic-research faculty-of-arts-and-sciences fas harvard peter-reuell reuell balskus chemotherapy emily-balskus enzyme nature nitrosamine soil soil-bacteria streptozotocin
Page 1 of 1